Skip to main content

AgTech Advisory FAQ - Fundraising & ESG | AixPoint

Expert answers on AgTech advisory, fundraising, farm robotics, AI, carbon credits, agrivoltaics and more. By Dirk Vandenhirtz, Aachen.

Frequently asked questions about AixPoint AgTech advisory Dirk Vandenhirtz, founder of AixPoint and AgTech advisor based in Aachen

Frequently Asked Questions — Deep-Tech Advisory, Fundraising and IP

Practical answers to the questions founders, investors and operators ask AixPoint most often. Each entry reflects how engagements actually run — not generic consulting boilerplate.

Engagement model

How does an engagement start? A free 30-minute scoping call followed by a written proposal with deliverables, milestones, and fees. AixPoint declines roughly 60 % of inbound mandates where the fit or stage is wrong.

Pricing. Fixed-fee mandates for scoped work (pitch deck overhaul, IP audit, fundraising prep). Monthly retainers for ongoing advisory. Equity-only arrangements only for portfolio companies.

Fundraising support

Typical timeline. 4–6 months from kickoff to term sheet for seed/Series A in AgTech and deep-tech, assuming clean data room and traction signals. Hardware and biotech rounds run longer.

Investor network. Curated relationships with European and US deep-tech funds, family offices and strategic corporates. Introductions are warm, sourced when there is a real fit, never blasted.

IP and patent strategy

When to file. Defensive freedom-to-operate analysis before any external pitch. Strategic filings timed to fundraising milestones, not arbitrary calendar dates.

Patent landscape audits. 2–3 week deliverable mapping competitor IP, white-space and licensing risk. Used by 6 of the last 10 portfolio companies.

Who AixPoint works with

AgTech, robotics, climate-tech, biotech, industrial software founders post-MVP. Investors with active deep-tech mandates seeking deal flow or due diligence support. Corporates exploring spin-outs or strategic acquisitions.

Related: Advisory services | Book a call | Client reviews | Track record